Centauri Therapeutics closes £24m Series A investment round

January 26, 2022 | News

Centauri Therapeutics is delighted to announce new investment of £24m in antimicrobial research and appointment of new company directors.

See attached press release

Categories

Related Posts

Centauri welcomes Matthew Bushdyhan

October 25, 2023 | News
Read More about Centauri welcomes Matthew Bushdyhan

Centauri Welcomes Adam Johnson

October 16, 2023 | News
Read More about Centauri Welcomes Adam Johnson

Centauri welcomes Dr Dave Chapman

September 25, 2023 | News
Read More about Centauri welcomes Dr Dave Chapman